Diagnostic Imaging

New Assessment Tool Predicts Pediatric Fracture Risk

New Assessment Tool Predicts Pediatric Fracture Risk

By

A new bone assessment evaluates fracture risk in children.

Disease Activity Evident on Foot MRI During Clinical Remission in Rheumatoid Arthritis

Disease Activity Evident on Foot MRI During Clinical Remission in Rheumatoid Arthritis

By

Our results demonstrate that a significant portion of patients classified as in clinical remission by DAS28 present some imaging findings suggesting disease activity in their clinical dominant foot

Ultrasound Finds Distinct Ankle Pathologies In Rheumatic Diseases

Ultrasound Finds Distinct Ankle Pathologies In Rheumatic Diseases

By

Ultrasonography detects different ankle pathologies in various inflammatory rheumatic diseases.

Prophylactic Hydration For Contrast-induced Nephropathy: Doubts About Efficacy, Cost-effectiveness

Prophylactic Hydration For Contrast-induced Nephropathy: Doubts About Efficacy, Cost-effectiveness

By

Study from The Netherlands randomly assigned 660 high-risk patients undergoing elective procedures involving iodinated contrast material to receive no prophylaxis or intravenous hydration.

Cognitive Dysfunction, Memory Impairment Evaluated by fMRI in Non-Neuropsychiatric SLE

Cognitive Dysfunction, Memory Impairment Evaluated by fMRI in Non-Neuropsychiatric SLE

By

Functional MRI imaging in patients with non-neuropsychiatric systemic lupus erythematosus found that defects in spatial working memory and cognitive dysfunction were related to damage in specific neural networks.

Whole Genome Sequencing Identifies Overlapping Molecular Disease

Whole Genome Sequencing Identifies Overlapping Molecular Disease

By

In 4.9% of cases that were ultimately informative with whole-exome sequencing, multiple molecular diagnoses were found.

Utility of Power Doppler in Guiding RA DMARD Modification

Utility of Power Doppler in Guiding RA DMARD Modification

By

Ultrasonography of clinician-specified joints may be used to guide modification of disease-modifying anti rheumatic drug (DMARD) and steroid therapy by further identifying joint inflammation in those patients with low systemic markers of inflammation.

Physicians Ordering Imaging Studies Lack Knowledge of Radiation Risks

Physicians Ordering Imaging Studies Lack Knowledge of Radiation Risks

By

Researchers examined knowledge of medical imaging examination radiation dose levels and potential risk among referring physicians, imaging technologists, and radiologists.

Does Invasive Provocative Discography Increase Risk of Disc Degeneration?

Does Invasive Provocative Discography Increase Risk of Disc Degeneration?

More lumbar surgeries in patients undergoing discography, and more medical visits, work loss, pain

Varus Alignment Correlates With Certain Radiographic Markers of Knee OA

Varus Alignment Correlates With Certain Radiographic Markers of Knee OA

By

A new study examined the association between varus knee alignment and radiographic progression of knee osteoarthritis.

SLE Disease Activity and Detectable Focal Changes in Cerebral Volume

SLE Disease Activity and Detectable Focal Changes in Cerebral Volume

By

This study showed that there are detectable differences in cerebral volume in patients with early SLE, and that control of SLE disease activity was associated with an increase of certain cerebral volumes.

What Does Medically Clearing Your Patient With Rheumatic Disease For Surgery Entail?

What Does Medically Clearing Your Patient With Rheumatic Disease For Surgery Entail?

By

Patients with rheumatic diseases face a variety of potential surgical complications as a result of either the disease itself or the medications used to manage it.

SI Joint Bone Marrow Edema and the Risk of Low BMD in AxSpA

SI Joint Bone Marrow Edema and the Risk of Low BMD in AxSpA

By

In patients with axial spondyloarthritis, deep bone edema detected on magnetic resonance imaging, increased C-reactive protein levels, and graded severity of sacroiliitis on x-ray were each independently associated with decreased bone mineral density.

Do Your Patients With RA Have Asymptomatic LV Systolic Dysfunction?

Do Your Patients With RA Have Asymptomatic LV Systolic Dysfunction?

By

RA appears to be an independent risk factor for left ventricular systolic dysfunction when stress-corrected mid-wall shortening is used as a surrogate marker for left ventricular systolic dysfunction.

Reducing CT Radiation With Indication-Specific Protocols

Reducing CT Radiation With Indication-Specific Protocols

By

Two simple methods were implemented by researchers to determine if total body radiation exposure can be decreased in patients visiting the emergency department while maintaining satisfactory diagnostic image quality.

Updated Recommendations for Development of Peak Bone Mass

Updated Recommendations for Development of Peak Bone Mass

By

Following a systematic evidence review, the National Osteoporosis Foundation (NOF) has developed practice guidelines based on the graded strength of current evidence.

Chondrocalcinosis Not Associated With Distinct Radiographic Phenotype in Knee, Hip OA

Chondrocalcinosis Not Associated With Distinct Radiographic Phenotype in Knee, Hip OA

By

Chondrocalcinosis in the knees and distal joints was associated with bone attrition in knee osteoarthritis. Hip chondrocalcinosis was associated with a milder hip osteoarthritis phenotype.

Semi-Automated Software Detects Erosion Volume in Patients With RA

Semi-Automated Software Detects Erosion Volume in Patients With RA

By

Authors of this study have developed a semiautomated software method to measure erosion volume seen on CT scans of the hand and wrist, in patients with RA.

Radiographs Identify Two Distinct Forms of Foot Osteoarthritis

Radiographs Identify Two Distinct Forms of Foot Osteoarthritis

By

Patterns of joint involvement in radiographic foot osteoarthritis have indicated a distinction between isolated first MTP joint OA and a more widespread form of OA.

Continued Structural Benefits Seen with MRI Following Abatacept Withdrawal in Early, Progressive RA

Continued Structural Benefits Seen with MRI Following Abatacept Withdrawal in Early, Progressive RA

By

Structural benefits associated with abatacept/methotrexate therapy or abatacept monotherapy are maintained 6 months after discontinuation of medication in patients who have achieved remission or low disease activity as assessed by MRI.

Contrast-Induced Nephropathy Risk Lowest With Iodixanol Prophylaxis

Contrast-Induced Nephropathy Risk Lowest With Iodixanol Prophylaxis

Systematic reviews that showed that contrast induced nephropathy (CIN) risk was lowest in patients receiving iodixanol, or for LOCM is lowest in patients receiving N-acetylcysteine concurrently with statins, but that the choice between the IOCM iodixanol and types of LOCM will not have a clinically important effect on CIN risk.

Sign Up for Free e-newsletters